Photoacoustic tomography provides both structural and functional imaging in vivo based on optical absorption contrast. A novel imaging system that incorporates a two-dimensional matrix ultrasound probe for combined photoacoustic and ultrasonic three-dimensional (3D) volumetric imaging is presented. The system consists of a tunable dye laser pumped by a Nd:YAG laser, a commercial ultrasound imaging system (Philips iU22) with a two-dimensional matrix transducer (Philips X7-2, 2500 elements, 2-7 MHz), and a multichannel data acquisition system which allows us to acquire RF channel data. Compared with alternative 3D techniques, this system is attractive because it can generate co-registered 3D photoacoustic and ultrasound images without mechanical scanning. Moreover, the lateral resolution along the azimuth and elevational directions are measured to be 0.77 ± 0.06 mm and 0.96 ± 0.06 mm, respectively, based on reconstructed photoacoustic images of phantoms containing individual human hairs. Finally, in vivo 3D photoacoustic sentinel lymph node mapping using methylene blue dye in a rat model is demonstrated.
INTRODUCTION
Photoacoustic imaging is a promising technology that combines image contrast based on optical absorption with ultrasonic resolution. The basis for photoacoustic wave generation is optical absorption by tissue structures that are illuminated by short pulses of light. Under stress and thermal confinement conditions, transient heating induces thermoelastic expansion and emission of acoustic pressure waves. These photoacoustic waves can be detected by conventional ultrasound array transducers for image reconstruction. Photoacoustic imaging overcomes the depth limitations of pure optical imaging techniques by utilizing ultrasonic detection, since acoustic scattering is 2-3 orders of magnitude less than optical scattering. It is capable of high-resolution structural, functional, and molecular imaging free from speckle artifacts. 1 Recently, efforts have been made to incorporate two-dimensional (2D) array transducers for efficient three-dimensional (3D) photoacoustic imaging. Specifically, a 2D capacitive micromachined ultrasonic transducer (CMUT) with 16 x 16 transducer elements has been developed for photoacoustic and ultrasonic imaging. 2 Mechanical scanning was used to simulate a larger 64 x64 element aperture for improved image quality. In addition, a 1.75D array transducer with 1280 elements (10 x 128) was constructed for ultrasonic and photoacoustic characterization of ex vivo ovarian tissue. 3 Also, a polyvinylidene fluoride (PVDF) matrix array hydrophone with 590 transducer elements was used as a photoacoustic receiver in a research prototype system for breast cancer detection. 4, 5 The advantage of 2D arrays is that 3D images can be acquired without mechanical scanning and, by using a small number of laser firings, achieve higher imaging frame rates than other systems. The trade-off is increased system complexity to manage data from a larger number of transducer elements.
A promising clinical application of photoacoustic imaging is for noninvasive sentinel lymph node mapping. Sentinel lymph nodes are the first nodes to receive drainage from the tumor, and as such, are most likely to contain metastatic tumor cells. Biopsy of sentinel lymph nodes is an effective method to determine if the cancer has spread beyond the primary tumor into the lymphatic system. Sentinel lymph node biopsy is critical for cancer staging to plan appropriate *todd.erpelding@philips.com therapy and evaluate prognosis, and has become the standard of care for axillary staging in newly diagnosed breast cancer patients. [6] [7] [8] The current method of sentinel lymph node biopsy depends on local injection of blue dyes and radioactive tracers that accumulate in sentinel nodes. Surgeons use incisions to invasively locate and excise sentinel nodes based on visual inspection for blue nodes and using Geiger counters to detect radioactive nodes. Excised nodes undergo pathological examination to determine the presence of metastases. A noninvasive method for sentinel lymph node identification could enable percutaneous needle biopsies as a viable option for axillary staging of breast cancer patients. The same blue dyes (i.e. methylene blue) currently used in clinical practice for sentinel lymph node biopsy can serve as photoacoustic contrast agents due to strong optical absorption by the dye. In vivo preclinical experiments in a rat model have successfully demonstrated noninvasive photoacoustic imaging of sentinel lymph nodes following injection of methylene blue, 9 indocyanine green, 10 gold nanoparticles, 11, 12 and carbon nanotubes. 13 A modified clinical ultrasound system capable of photoacoustic imaging has highlighted the potential for clinical translation of photoacoustic sentinel lymph node mapping. [14] [15] [16] In this report, the modified clinical ultrasound system has been extended to enable 3D photoacoustic and ultrasound imaging using a 2D matrix array transducer. This is the first time to our knowledge that 3D photoacoustic imaging has been demonstrated using a clinical 2D matrix array ultrasound transducer. The performance of this multi-modal 3D imaging system has been evaluated using resolution phantoms and for in vivo sentinel lymph node mapping.
METHODOLOGY

Photoacoustic imaging system
A prototype photoacoustic imaging system ( Figure 1 ) has been built around a Philips iU22 ultrasound scanner (Philips Healthcare, Andover, MA). [14] [15] [16] The modified channel board architecture allowed access to raw per-channel photoacoustic RF data, while retaining all imaging capabilities of an actual commercial ultrasound scanner. Raw photoacoustic and ultrasound RF data were transferred to a custom-built data acquisition system for post-processing image reconstruction, providing dual-modality imaging capability. The 2D matrix array probe X7-2 (2500 elements) with nominal bandwidth 2-7 MHz was used for 3D photoacoustic and ultrasound imaging. Currently, one photoacoustic volume image is generated from 36 lasers shots, requiring 20 seconds for data acquisition followed by offline image reconstruction using a 3D delay and sum beamforming algorithm implemented in Matlab (MathWorks Inc., Natick, MA). An FPGA-based electronic board and separate delay generator (Stanford Research Systems, Sunnyvale, CA) synchronized iU22 data acquisition with laser firings. The X7-2 transducer performs micro-beamforming within the transducer to reduce the number of system channels needed for the large number of transducer elements. The microbeamforming process performed within the transducer is reversed offline using a novel, proprietary algorithm to recover raw photoacoustic channel data. Photoacoustic maximum amplitude projection (MAP) images were reconstructed by first removing the skin signal and then projecting the remaining maximum signal amplitude along each A-line onto the corresponding x -y plane. Volumetric photoacoustic images were visualized by using VolView software (Kitware, Clifton Park, NY).
Light from a tunable dye laser (PrecisionScan-P, Sirah, Kaarst, Germany), pumped by a Q-switched Nd:YAG laser (PRO-350-10, Spectra-Physics, Santa Clara, CA) with 6.5-ns pulse duration and 10-Hz pulse repetition rate, was delivered via a fused end, bifurcated fiber bundle (LightGuideOptics, Rheinbach, Germany). Photoacoustic images were acquired using 650 nm light, which is close to the peak absorption wavelength for methylene blue dye. The light fluence on the skin was less than 10 mJ/cm 2 , within American National Standards Institute safety limits. 17 The fiber bundles were mounted to the matrix array probe to enable dual-modality 3D photoacoustic and ultrasonic imaging without mechanical scanning. The ultrasound probe was partially immersed in a water tank which had an opening at the bottom sealed with a thin, disposable, clear membrane. Rats were placed below the water tank, in contact with the membrane via ultrasonic coupling gel.
Resolution phantom preparation
To investigate the spatial resolution of the matrix probe, we imaged human hairs embedded within a gelatin phantom. A hot gelatin water solution (10% by weight) was made and congealed in mold. Two hairs were placed on top and another layer of gelatin was poured, completely covering the hairs. The gelatin phantom was placed in a water bath with the ultrasound transducer positioned 2 cm above the hairs.
Animal and dye preparation
Animal protocols were approved by the Washington University Animal Studies Committee and animal handling was performed according to the guidelines on the care and use of laboratory animals. Healthy Sprague Dawley rats (N = 3) were anesthetized using a mixture of ketamine (85 mg/kg) and xylazine (15 mg/kg). The hair in the left axillary region was gently depilated before imaging. Photoacoustic and ultrasound images were collected before and after 100 μL intradermal injection of 1% methylene blue dye (10 mg/mL, American Reget, Inc., Shirley, NY) into the left forepaw pad. Photoacoustic images were collected at 5 minute intervals for up to 30 minutes post-injection, with an additional time point collected at 2.5 min post-injection. After imaging, animals were euthanized with an overdose of pentobarbital, and SLNs were dissected. Figure 1 . Experimental setup of the 3D photoacoustic imaging system adapted from a modified Philips iU22 ultrasound (US) imaging system (Philips Healthcare, Andover, MA).
RESULTS
Resolution phantom imaging
Photoacoustic images of two human hairs embedded within a gelatin phantom yield estimates of the spatial resolution of the matrix array transducer (Fig. 2) . 
In vivo 3D photoacoustic SLN mapping
Photoacoustic imaging with the matrix array transducer has been successfully demonstrated in vivo for 3D SLN mapping (Fig. 3) . Photoacoustic MAP images show the accumulation of methylene blue dye in a rat SLN at 0, 5, and 30 minutes post-injection (Fig. 3 b, c, d ). The 0 minute time point was acquired immediately following methylene blue injection and shows a substantial increase in the mean photoacoustic signal amplitude from the SLN region compared with the control photoacoustic MAP image acquired prior to methylene blue injection (Fig. 3a) . This signal increase reflects the rapid collection of methylene blue by lymphatic vessels in the rat forepaw and subsequent accumulation in the SLN. Since the methylene blue injection lasted about 10 seconds and 3D data acquisition took 20 seconds, the 0 minute time point consists of photoacoustic signals received up to 30 seconds after the start of the injection.
The dynamic increase in photoacoustic signal amplitudes from SLN regions following methylene blue injection is displayed according to mean and standard deviation (Fig. 3e) . Photoacoustic signal amplitudes are plotted relative to the pre-injection signal amplitude from the same region-of-interest. Photoacoustic signal amplitudes at 30 minutes post-injection increase approximately 20 times compared to the pre-injection baseline signal amplitudes, illustrating the strong contrast enhancement provided by methylene blue. The dynamics of methylene blue accumulation in a rat lymph node represented by the photoacoustic signal amplitude is consistent with previous reports, reaching peak signal amplitudes at 20-30 minutes post-injection. 14 The accumulation of methylene blue dye in the rat SLN was confirmed by postmortem dissection (Fig. 3f) .
Co-registered 3D photoacoustic and ultrasound images depict functional, represented by methylene blue accumulation, and structural information, represented by morphological features (Fig. 4) . The location of the sentinel lymph node relative to the surrounding anatomy can be best appreciated in co-registered 3D photoacoustic and ultrasound images. Figure 4a illustrates a co-registered volume image with the indicated 2D B-mode slice depicted in Fig. 4b . 
DISCUSSION
A modified clinical ultrasound system has been adapted for 3D photoacoustic imaging using a 2D matrix array transducer. The addition of 3D photoacoustic imaging to this system provides an additional contrast mechanism based on optical absorption. The current system acquires a complete 3D photoacoustic dataset in 20 seconds from 36 laser firings and performs offline image reconstruction of a 4 x 4 x 5 cm 3 volume. Compared to previous photoacoustic imaging systems developed around 2D matrix array transducers, [2] [3] [4] [5] this system offers fast photoacoustic data acquisition, submillimeter spatial resolution, and incorporates the full 3D ultrasound imaging functionality offered by the commercial iU22 system. The 3D ultrasound modes currently available on the system include live 3D imaging and live biplane imaging for real-time display of two planes simultaneously. Further system development could reduce the number of laser firings required and produce a photoacoustic volume image in real-time at a reasonable frame rate. Faster imaging frame rates will enable hand-held scanning, which is needed to fully realize the potential of 3D photoacoustic imaging with 2D matrix array transducers. The feasibility of 3D photoacoustic imaging using a modified clinical ultrasound imaging system has been established, which represents an important development towards this goal.
The results demonstrate the utility of the current system for dynamic 3D photoacoustic imaging in vivo. 3D photoacoustic images show the accumulation of methylene blue dye within a rat sentinel lymph node in the first 30 minutes following dye injection. Strong photoacoustic contrast enhancement (~20x) resulted from methylene blue accumulation in the rat lymph node, which highlights the potential of this clinically-used dye. 3D photoacoustic imaging could offer unique clinical advantages for improved visualization of multiple sentinel nodes, as typically 1-3 nodes are removed during sentinel lymph node biopsy. Finally, percutaneous needle biopsies of sentinel lymph nodes could be guided more efficiently by 3D photoacoustic and ultrasound imaging than by 2D imaging alone.
